Evidence map›Paper›PMID 37457264›Full record

ArticleFrontiers in public health2023

Daniel A Salmon, Matthew Z Dudley, Janesse Brewer, Jana Shaw, Holly B Schuh, Tina M Proveaux, Amelia M Jamison, Amanda Forr, Michelle Goryn, Robert F Breiman and 25 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Frontiers in public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

35 authors at 13 institutions in 2 countries.

Daniel A SalmonInstitute for Vaccine Safety, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States.
Matthew Z DudleyInstitute for Vaccine Safety, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States.
Janesse BrewerInstitute for Vaccine Safety, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States.
Jana ShawDepartment of Public Health and Preventive Medicine, State University of New York, Upstate Medical University, Syracuse, NY, United States.
Holly B SchuhDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
Tina M ProveauxInstitute for Vaccine Safety, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States.
Amelia M JamisonDepartment of Health, Behavior, and Society, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States.
Amanda ForrInstitute for Vaccine Safety, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States.
Michelle GorynInstitute for Vaccine Safety, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States.
Robert F BreimanDepartment of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, United States.
Walter A OrensteinDivision of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, United States.
Lee-Sien Kaoieas42.org, New York, NY, United States.
Robina Josiah WillockDepartment of Community Health and Preventive Medicine, Morehouse School of Medicine, Atlanta, GA, United States.
Michelle CantuDepartment of Immunization, National Association of County and City Health Officials, Washington, DC, United States.
Tori DeceaDepartment of Immunization, National Association of County and City Health Officials, Washington, DC, United States.
Robin MowsonDepartment of Immunization, National Association of County and City Health Officials, Washington, DC, United States.
Kate TsubataBonnemaison, Baltimore, MD, United States.
Lucie Marisa BucciBucci-Hepworth Health Services Inc., Pincourt, QC, Canada.
Jaqueline LawlerOrange County Department of Health, Goshen, NY, United States.
James D WatkinsWilliams County Combined Health District, Montpelier, OH, United States.
Jamie W MooreGuilford County Division of Public Health, Greensboro, NC, United States.
James H FugettGuilford County Division of Public Health, Greensboro, NC, United States.
Adriele FugalMonongalia County Health Department, Morgantown, WV, United States.
Yazmine TovarMonongalia County Health Department, Morgantown, WV, United States.
Marie GayOrange County Department of Health, Goshen, NY, United States.
Aleen M CaryInstitute for Vaccine Safety, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States.
Iulia VannUtah County Health Department, Provo, UT, United States.
Lee B SmithGuilford County Division of Public Health, Greensboro, NC, United States.
Lilly KanDepartment of Immunization, National Association of County and City Health Officials, Washington, DC, United States.
Magda MankelBorder Studies Program, Earlham College, Tucson, AZ, United States.
Sumayya BeekunDepartment of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States.
Victoria SmithWilliams County Combined Health District, Montpelier, OH, United States.
Stephanie D AdamsCenter for Global Health Innovation, Atlanta, GA, United States.
Steven A HarveyDepartment of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States.
Peter Z OrtonInstitute for Vaccine Safety, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States.
Johns Hopkins University · USNational Association of County and City Health Officials · USGuilford County Schools · USEmory University · USFlorida Department of Health in Orange County · USMon Health Medical Center · USWilliams (United States) · USAlberta Health Services · CACenter for Global Health · USEarlham College · USInstitute for Expressive Analysis · USMorehouse School of Medicine · USSUNY Upstate Medical University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Vaccine hesitancy is a global health threat undermining control of many vaccine-preventable diseases. Patient-level education has largely been ineffective in reducing vaccine concerns and increasing vaccine uptake. We built and evaluated a personalized vaccine risk communication website called Methods: We used mixed-methods research to test our animation and some aspects of credible sources and personal narratives. We conducted 67 discussion groups ( Results: Discussion groups provided robust feedback specific to each animation as well as areas for improvements across animations. Most respondents indicated that the information presented was interesting (85.5%), clear (96.0%), helpful (87.0%), and trustworthy (82.2%). Discussion: Tailored vaccine risk communication can assist decision makers as they consider vaccination for themselves, their families, and their communities.

Indexed as

CommunicationVaccinationVaccinesAdolescentAgedBlack or African AmericanCanadaChildFemaleHealth EducationHealth PromotionHispanic or LatinoHumansParentsPrecision MedicinePregnancyVaccinescommunicationCOVID-19tailored applicationvaccine hesitancyvaccines

Identifiers

PMID37457264
PMCPMC10348877
OpenAlexW4382751799

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.